Status:
COMPLETED
Effect of Oral Phloroglucin (Flospan®) as Premedication of Non-sedative Diagnostic Esophagogastroduodenoscopy
Lead Sponsor:
Keimyung University Dongsan Medical Center
Conditions:
Anti-spasmodics
Gastric Peristalsis
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
Gastric peristalsis, which occurs during the endoscopic procedure, limits the visual inspection of the inspection field, causing interference in the inspection. The actual endoscopic examination is mo...
Detailed Description
Background : Endoscopy is currently widely regarded as the most important test in diagnosing stomach disorders, including stomach cancer. Gastric peristalsis, which occurs during the endoscopic proced...
Eligibility Criteria
Inclusion
- patients who perform non-sedative endoscopy for diagnosis or screening purposes.
- patients who understand and follow the directions and questionnaires of clinical trials.
- patients who have decided to voluntarily participate in this clinical trial and have agreed in writing
Exclusion
- Patients who performed Upper GI surgery.
- Severe gastric outlet obstruction or malformations or gastroparesis
- Patients who have severe cognitive impairment
- Pregnant or lactation patients
- Patients who need to hemostasis for upper GI bleeding
- Hemodynamic unstable patients
- Above American Society of Anesthesiology classification class 4
Key Trial Info
Start Date :
September 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 29 2017
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT03342118
Start Date
September 21 2017
End Date
December 29 2017
Last Update
January 3 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KeimyungUniversity
Daegu, Jung-gu, South Korea, 700-712